Mayne Pharma Group Ltd Sustainability Reports
Mayne Pharma Group Limited is a specialty pharmaceutical company focused on developing, manufacturing, and commercializing novel and generic pharmaceuticals. The company operates primarily in core therapeutic areas spanning women's health and dermatology.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 549300VIRDEN0N4MJG59
FIGI: BBG001SDB363
16 reports from 2015 to 2026
